跳至主要内容
临床试验/NCT04827914
NCT04827914进行中(未招募)不适用

Dissemination of an Inpatient Smoking Cessation Program to South Carolina Hospitals Study #1

Medical University of South Carolina8 个研究点 分布在 1 个国家目标入组 1,122 人开始时间: 2021年3月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,122
试验地点
8
主要终点
Self-reported smoking prevalence 6-weeks after hospitalization.

研究概览

简要总结

The modest goal of this study is to replicate the behavioral outcomes of the opt out MUSC-Tobacco Treatment Program in the following three patient groups: 1) psychiatric inpatients housed in the Institute of Psychiatry (IOP) in Charleston; 2) non-IOP patients seen in Charleston; and 3) patients seen in the other four MUSC affiliated hospitals combined (i.e., Chester, Florence, Lancaster, and Marion). The aims and the design/methods utilized for evaluation will be the same for each of the three patient groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18+ years and older
  • hospitalized cigarette smokers eligible for either enhanced or basic care
  • discharged from the hospital back to their home

排除标准

  • patients without a phone number
  • those unable to communicate in the English language

结局指标

主要结局

Self-reported smoking prevalence 6-weeks after hospitalization.

时间窗: Assessed 6-weeks post-discharge

Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2-fold higher 7-day non-smoker prevalence rate after hospitalization (i.e., 20% vs 10%)

Self-reported use of FDA Approved Smoking Cessation Medication

时间窗: Assessed 6-weeks post-discharge

Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2.5-fold greater use of an FDA approved stop smoking medication after hospitalization (i.e., 20% vs 8%)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验